Intravenous (IV) Equipment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented Type (IV Catheters, Infusion Pumps, Securement Devices, Administration Sets, Drip Chambers, Other Types), By End-User (Hospitals, Ambulatory Surgical Centers, Other End-Users), By Region & Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 13.78 Billion
CAGR (2026-2031)	5.38%
Fastest Growing Segment	Infusion Pumps
Largest Market	North America
Market Size (2031)	USD 18.87 Billion

Market Overview

The Global Intravenous (IV) Equipment Market will grow from USD 13.78 Billion in 2025 to USD 18.87 Billion by 2031 at a 5.38% CAGR. Intravenous equipment comprises medical devices such as catheters and infusion pumps designed to deliver fluids and medications directly into the venous circulation. The primary drivers fueling market growth include the escalating prevalence of chronic diseases and an aging global population that requires consistent medical intervention. These factors necessitate reliable vascular access for administering therapeutics in both critical and long term care settings. According to the American Hospital Association, in 2025, the total number of admissions in all United States hospitals reached approximately 34.4 million. This high volume of inpatient care underscores the substantial and continuous demand for intravenous therapies to support patient recovery and disease management.

However, a significant challenge impeding market expansion involves the stringent regulatory requirements regarding patient safety and device reliability. Manufacturers face hurdles related to medication errors and device malfunctions which frequently lead to product recalls and rigorous compliance audits. These safety concerns necessitate extensive clinical validation and strict adherence to quality standards that prolong product development cycles. Consequently, the high costs associated with regulatory approval and potential liability claims can restrain market entry and hinder the rapid adoption of new infusion technologies.

Key Market Drivers

Technological advancements in smart IV infusion systems are fundamentally reshaping the market by enhancing patient safety and workflow efficiency. Modern infusion pumps now integrate dose error reduction software and wireless connectivity, allowing seamless interoperability with electronic medical records. These features mitigate the risk of medication errors, a critical concern for healthcare providers, thereby accelerating the replacement of legacy devices with intelligent platforms that ensure precise fluid delivery. According to Becton, Dickinson and Company, November 2025, in the 'Fourth Quarter and Full Year Fiscal 2025 Financial Results', the company reported total annual revenues of $21.8 billion, a performance bolstered by the commercial launch of new AI-enabled connected care solutions. This financial growth reflects the industry-wide priority on deploying systems that support real-time monitoring and data integration.

The growing adoption of home-based healthcare services acts as a parallel catalyst, expanding the utilization of intravenous equipment beyond traditional hospital walls. As healthcare systems strive to reduce inpatient costs and manage the rising burden of chronic lifestyle diseases, there is a marked shift toward administering parenteral nutrition and antibiotic therapies in domiciliary settings. This transition demands robust, portable infusion pumps designed for safe use by non-clinical operators. According to Baxter International Inc., May 2025, in the 'First Quarter 2025 Earnings' report, the Medical Products and Therapies segment achieved approximately $1.26 billion in sales, driven by sustained demand for infusion systems and nutrition therapies. Furthermore, the broader market continues to face supply pressures; according to ICU Medical, Inc., February 2025, in the 'Fourth Quarter 2024 Results', the company recorded $629.8 million in quarterly revenue, partially attributed to increased sales of IV solutions amid persistent market shortages.

Download Free Sample Report

Key Market Challenges

Stringent regulatory requirements regarding patient safety and device reliability constitute a significant impediment to the Global Intravenous (IV) Equipment Market. Manufacturers must navigate complex approval pathways and maintain impeccable quality control to prevent medication errors and device malfunctions. When these safety standards are not met, companies face costly product recalls and extensive compliance audits, which drain financial resources and delay the commercialization of advanced infusion technologies. This regulatory burden forces manufacturers to allocate substantial capital toward validation and remediation rather than innovation, thereby slowing the overall market expansion.

According to the Emergency Care Research Institute (ECRI), in 2025, 'Incomplete Investigations of Infusion System Incidents' was ranked as the 10th most critical health technology hazard. This classification highlights the persistent industry-wide struggle to adequately address and resolve device failures efficiently. The heightened scrutiny arising from such documented safety hazards increases liability risks and prompts healthcare providers to hesitate in adopting new systems without extensive proven track records. Consequently, the high operational costs and reputational risks associated with these regulatory hurdles directly restrain the rapid growth and adoption of intravenous equipment.

Key Market Trends

The transition toward sustainable and biodegradable IV equipment materials is fundamentally altering manufacturing practices as the industry addresses its significant environmental footprint. Medical device companies are increasingly adopting circular economy principles, replacing polyvinyl chloride (PVC) and diethylhexyl phthalate (DEHP) with eco-friendly alternatives and implementing rigorous waste reduction strategies in production cycles. This shift is driven by escalating demand from healthcare institutions for greener supply chains and compliance with tightening global environmental regulations. According to B. Braun Medical Ltd, April 2025, in the 'Carbon Reduction Plan', the company reported total Scope 1 and 2 greenhouse gas emissions of 1,470 tCO2e for the reporting year 2024, reflecting a strategic operational pivot toward decarbonization and resource efficiency in their manufacturing processes.

Concurrently, the growth of specialized outpatient infusion clinics and centers is establishing a critical middle ground between high-cost inpatient care and home-based settings. Unlike domiciliary care which suits stable chronic management, these ambulatory centers provide a medically supervised environment essential for administering complex high-acuity biologics and oncology therapies that require immediate clinical oversight. This model significantly reduces healthcare expenditures by diverting patients away from expensive hospital admissions while ensuring safety for intricate infusion protocols. According to Option Care Health, Inc., April 2025, in the 'First Quarter 2025 Earnings' report, the company achieved net revenue of $1.33 billion, representing a 16.3% increase year-over-year, underscoring the rapid expansion and financial viability of these alternate site infusion services.

Segmental Insights

Infusion pumps currently represent the fastest-growing segment within the Global Intravenous (IV) Equipment Market. This rapid expansion is primarily driven by the increasing global prevalence of chronic diseases, such as diabetes and cancer, which necessitate precise and long-term medication administration. Furthermore, the industry is witnessing a significant shift toward home-based healthcare, fueling the demand for portable and ambulatory pump systems. The integration of smart software to ensure dosing accuracy further supports this trend, directly addressing strict safety mandates enforced by regulatory bodies like the U.S. Food and Drug Administration.

Regional Insights

North America maintains a leading position in the global intravenous equipment market, largely due to established healthcare infrastructure and significant healthcare expenditure within the United States. This dominance is reinforced by the rising prevalence of chronic conditions that require continuous infusion therapies. Additionally, the U.S. Food and Drug Administration (FDA) enforces rigorous safety standards that sustain product quality and reliability. The sector further benefits from comprehensive reimbursement policies overseen by the Centers for Medicare & Medicaid Services (CMS), which facilitate broader patient access to necessary infusion devices and support consistent market expansion.

Recent Developments

• In April 2025, ICU Medical, Inc. received 510(k) regulatory clearance from the U.S. Food and Drug Administration for the Plum Solo precision IV pump. This approval introduced a single-channel infusion device that complements the company's existing dual-channel technology, expanding the ICU Medical IV Performance Platform. The new pump was designed to deliver high accuracy in real-world clinical conditions and facilitate better data integration with electronic health records. This product launch represented a strategic move to provide healthcare facilities with a more flexible and comprehensive range of infusion pump options.
• In January 2025, Fresenius Kabi released a significant software update for its Ivenix Infusion System to enhance the platform's capabilities in hospital settings. The release of the Large Volume Pump software version 5.10 introduced new features designed to improve interoperability and streamline infusion workflows. This update addressed specific clinical needs by optimizing the management of infusion data and supporting safer medication delivery. The Ivenix system is a key component of the company's offering in the Global Intravenous (IV) Equipment Market, utilizing a unique pneumatic pumping mechanism.
• In January 2025, Becton, Dickinson and Company showcased its latest advancements in drug delivery systems at the Pharmapack event in Europe. The company highlighted the BD Hylok Glass Prefillable Syringe, a device specifically engineered for the administration of viscous intravenous drugs and hyaluronic acid. This product launch addressed the growing demand for prefillable solutions that ensure container closure integrity and compatibility with complex biologic formulations. The presentation demonstrated the company's continued focus on expanding its range of specialized equipment for intravenous and parenteral drug administration.
• In September 2024, B. Braun Medical Inc. received 510(k) clearance from the U.S. Food and Drug Administration for the Introcan Safety 2 Deep Access IV Catheter. This new device was added to the company's portfolio to provide a solution for patients with difficult vascular access. The catheter features a longer length designed to access deeper veins, which allows for longer dwell times and reduces the need for invasive central lines. It also incorporates automatic passive needlestick protection and a multi-access blood control hub to enhance safety for clinicians during intravenous therapy procedures.

Key Market Players

• 3D Systems, Inc.
• 3M Company
• Baxter International
• Becton, Dickinson and Company
• B. Braun Melsungen AG
• EuroLife Healthcare Pvt. Ltd
• Henry Schein, Inc
• ICU Medical, Inc
• Polymedicure
• Terumo Corporation
• Teleflex Incorporated

By End-User	By Region
Hospitals Ambulatory Surgical Centers Other End-Users	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Intravenous (IV) Equipment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Intravenous (IV) Equipment Market, By End-User:

• Hospitals
• Ambulatory Surgical Centers
• Other End-Users

• Intravenous (IV) Equipment Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE